Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More support for prenatal MVMs

This article was originally published in The Tan Sheet

Executive Summary

Continued improvements in the infant and maternal mortality rates will depend on interventions before a woman becomes pregnant, according to officials from the March of Dimes, CDC and other experts. "Preconception Care for Improving Perinatal Outcomes: The Time to Act," was published Sept. 19 as part of the Maternal & Child Health Journal. The supplement includes the use of multivitamins with folic acid to prevent birth defects. Recently the Canadian Health Food Association promoted multivitamin compliance as a way to reduce healthcare costs, (1"The Tan Sheet" Sept. 11, 2006, In Brief)...

You may also be interested in...



CHFA on multivitamins

The Canadian Health Food Association is using a recently published meta-analysis of multivitamin use and the prevention of birth defects to promote multivitamin compliance as a way to reduce healthcare costs, according to a Sept. 1 release from the trade group. "Research continues to show that multivitamins are a simple, cost-effective way to support improved immune function and help prevent chronic disease," CHFA President Valerie Bell says in the release. The study in the August Journal of Obstetrics & Gynecology of Canada finds use of folic-acid containing prenatal multivitamins was associated with a decreased risk for several congenital anomalies, not only neural tube defects, according to Y. Ingrid Goh, Department of Pharmaceutical Sciences, University of Toronto, Canada, et al. The authors suggest reconsidering the current approach of recommending only folic acid in light of their research. In May, a panel convened by NIH determined current data was "insufficient" to make a conclusive recommendation for or against the use of multivitamins in the prevention of chronic diseases (1"The Tan Sheet" May 22, 2006, p. 6)...

UK IVDs Firms Working Flat Out On COVID-19 Tests, As Govt Promises Test Capacity Increase

Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.

Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi

Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients

Topics

UsernamePublicRestriction

Register

PS099785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel